Get started
Author

Margaret Siwale

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study
2011 · Raph L Hamers, Carole L Wallis, et al. · The Lancet Infectious Diseases · 287
Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study
2011 · Raph L Hamers, Rob Schuurman, et al. · The Lancet Infectious Diseases · 191
Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa
2011 · Kim C E Sigaloff, Raph L Hamers, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 185
Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies
2012 · R. L. Hamers, K. C. E. Sigaloff, et al. · Clinical Infectious Diseases · 166
PDF
Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa
2016 · T. Sonia Boender, Cissy M. Kityo, et al. · Journal of Antimicrobial Chemotherapy · 99
PDF
Adherence to antiretroviral therapy for HIV in sub‐Saharan Africa and Asia: a comparative analysis of two regional cohorts
2017 · Rimke Bijker, Awachana Jiamsakul, et al. · Journal of the International AIDS Society · 93
PDF
Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study
2018 · Seth C Inzaule, Raph L Hamers, et al. · The Lancet HIV · 78
Second-Line Antiretroviral Treatment Successfully Resuppresses Drug-Resistant HIV-1 After First-Line Failure: Prospective Cohort in Sub-Saharan Africa
2012 · K. C. E. Sigaloff, R. L. Hamers, et al. · The Journal of Infectious Diseases · 69
Pretreatment HIV Drug Resistance Increases Regimen Switches in Sub-Saharan Africa
2015 · T. Sonia Boender, Bernice M. Hoenderboom, et al. · Clinical Infectious Diseases · 67
PDF
Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa
2018 · Stefanie Kroeze, Pascale Ondoa, et al. · AIDS · 66
Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance—HIV drug resistance in sub-Saharan Africa and the Asia-Pacific
2010 · Raph L Hamers, Rebecca Oyomopito, et al. · International Journal of Epidemiology · 62
PDF
HIV–HBV Coinfection in Southern Africa and the Effect of Lamivudine- Versus Tenofovir-Containing cART on HBV Outcomes
2013 · Raph L. Hamers, Hans L. Zaaijer, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 61
Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa
2016 · T. Sonia Boender, Raph L. Hamers, et al. · The Journal of Infectious Diseases · 52
PDF
Plasma Biomarkers of Human Immunodeficiency Virus–Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy
2019 · Stefanie Kroeze, Ferdinand W Wit, et al. · The Journal of Infectious Diseases · 43
PDF
HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia
2010 · Raph L Hamers, Margaret Siwale, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 39
Long-term HIV treatment outcomes and associated factors in sub-Saharan Africa: multicountry longitudinal cohort analysis
2022 · Seth C. Inzaule, Stefanie Kroeze, et al. · AIDS · 26
The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa
2020 · Seth C. Inzaule, Silvia Bertagnolio, et al. · AIDS · 25
PDF
Early Warning Indicators for Population-Based Monitoring of HIV Drug Resistance in 6 African Countries
2012 · Kim C. E. Sigaloff, Raph L. Hamers, et al. · Clinical Infectious Diseases · 25
Optimism alongside new challenges: using a rehabilitation framework to explore experiences of a qualitative longitudinal cohort of people living with HIV on antiretroviral treatment in Lusaka, Zambia
2017 · Stephanie A. Nixon, Virginia Bond, et al. · AIDS Care · 22
Building Capacity for the Assessment of HIV Drug Resistance: Experiences From the PharmAccess African Studies to Evaluate Resistance Network
2012 · R. L. Hamers, E. Straatsma, et al. · Clinical Infectious Diseases · 12
PDF
Access to HIV Viral Load Testing and Antiretroviral Therapy Switch Practices: A Multicountry Prospective Cohort Study in Sub-Saharan Africa
2020 · Pascale Ondoa, Andrea A. Kim, et al. · AIDS Research and Human Retroviruses · 11
Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance
2018 · Seth C. Inzaule, Cissy M. Kityo, et al. · Scientific Reports · 11
PDF
Plasma Inflammatory Biomarkers Predict CD4+ T-cell Recovery and Viral Rebound in HIV-1 Infected Africans on Suppressive Antiretroviral Therapy
2020 · Stefanie Kroeze, Theresa M Rossouw, et al. · The Journal of Infectious Diseases · 7
Socioeconomic and Reproductive Factors Associated with Condom Use within and outside of Marriage among Urban Pregnant Women in Zambia
2005 · Chipepo Kankasa, Margaret Siwale, et al. · African Journal of Reproductive Health · 6
Infant feeding counseling within Kenyan and Zambian PMTCT services: How well does it promote good feeding practices?
2003 · Rutenberg, Naomi, Kankasa, Chipepo, et al. · 5
PDF
Works count: 30
Citation count: 1,717
H-index: 19
I10-index: 22
Year
Topic
Type